Total | Condylar alterations | No condylar alterations | P | |
---|---|---|---|---|
Total, n (% girls) | 158 (73) | 68 (78) | 90 (70) | 0.26 |
Duration, yrs, median (25/75th percentile) | 2.5 (0.5/3.9) | 2.8 (0.6/4.7) | 2.3 (0.4/3.2) | 0.21 |
“EU 1 any time”, n (%) | 15 (9) | 9 (13) | 6 (7) | 0.11 |
Number of “active disease periods”, median (25/75th percentile) | 2.49 (1.0/3.0) | 2.87 (1.0/4.0) | 2.28 (1.0/3.0) | 0.06 |
“Potent medication” any time, n (%) | 75 (47) | 41 (60) | 34 (38) | 0.01 |
Number of “medication periods”, median (25/75th percentile) | 2.69 (1.0/4.0) | 3.06 (1.0/4.0) | 2.41 (1.0/3.0) | 0.02 |
Both “MTX and TNF-alpha inhibitor” any time, n (%) | 43 (27) | 23 (34) | 20 (22) | 0.09 |
“EU 1 or potent medication” any time, n (%) | 82 (52) | 43 (63) | 39 (43) | 0.01 |
“EU 1 and potent medication” any time, n (%) | 15 (10) | 11 (16) | 4 (4) | 0.02 |